Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for BrightSpring Health Services (BTSG) over the last 3 years, with Q3 2025 value amounting to $2.5 million.

  • BrightSpring Health Services' Asset Writedowns and Impairment fell 1049.63% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 6832.94%. This contributed to the annual value of $10.2 million for FY2024, which is 372.5% down from last year.
  • According to the latest figures from Q3 2025, BrightSpring Health Services' Asset Writedowns and Impairment is $2.5 million, which was down 1049.63% from $608000.0 recorded in Q2 2025.
  • BrightSpring Health Services' Asset Writedowns and Impairment's 5-year high stood at $5.5 million during Q4 2024, with a 5-year trough of $211000.0 in Q2 2024.
  • Its 3-year average for Asset Writedowns and Impairment is $2.5 million, with a median of $2.3 million in 2023.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first crashed by 9459.67% in 2024, then soared by 18815.17% in 2025.
  • Quarter analysis of 3 years shows BrightSpring Health Services' Asset Writedowns and Impairment stood at $2.3 million in 2023, then soared by 133.48% to $5.5 million in 2024, then tumbled by 54.03% to $2.5 million in 2025.
  • Its Asset Writedowns and Impairment stands at $2.5 million for Q3 2025, versus $608000.0 for Q2 2025 and $3.4 million for Q1 2025.